Cost-effectiveness of salmeterol/fluticasone combination therapy vs. fluticasone propionate in Japanese asthmatic patients

Yakugaku Zasshi

Volumn 130, Issue 4, 2010, Pages 593-603

  Tohda, Yuji ^a,e   Nishima, Sankei ^b,e   Arakawa, Ichiro ^c   Shiragami, Makoto ^c   Miyamoto, Terumasa ^d,e  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION   (Japan)

^c NIHON UNIVERSITY   (Japan)

^d Japan Clinical Allergy Research Institute   (Japan)

^e Kasuya Bldg ^*  (Japan)

Author keywords

Asthma; Economics; Fluticasone propionate; Salmeterol fluticasone; Total control

Indexed keywords

ADRENALIN; AMINOPHYLLINE; ANTIASTHMATIC AGENT; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; HYDROCORTISONE SODIUM SUCCINATE; IPRATROPIUM BROMIDE; SOLITA; UNCLASSIFIED DRUG;

ARTICLE; ASTHMA; COMPARATIVE STUDY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; DISEASE MANAGEMENT; DRUG COST; HUMAN; JAPANESE; POSITIVE END EXPIRATORY PRESSURE; TREATMENT DURATION;

EID: 77950415010     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.130.593     Document Type: Article

References (25)

1. Inagaki N., Allergology & Immunology, 14, 658-674 (2007). (in Japanese)
2. Usmani O. S., Maneechotesuwan K., Ito M., Johnson M., Barnes P. J., Adcock I. M., Am. J. Respir. Crit. Care Med., 172, 704-712 (2005).
3. Jenkins C., Woolcock A. J., Saarelainen P., Lundback B., James M. H., Respir. Med., 94, 715-723 (2000).
4. Theophilus A., Moore A., Prime D., Rossomanno S.,Whitcher B., Chrystyn H., Int. J. Pharm., 313, 14-22 (2006).
5. Nelson H. S., Busse W. W., Kerwin E., Church N., Emmett A., Rickard K., Knobil K., J. Allergy. Clin. Immunol., 106, 1088-1095 (2000).
6. Adachi M., Ohta K., Sano Y., Taniguchi H., Ishihara K., Aizawa H., Nakajima M., Allergology & Immunology, 12, 922-935 (2005). (in Japanese)
7. Stoloff S. W., Stempel D. A., Meyer J., Stanford R. H., Carranza Rosenzweig J. R., J. Allergy Clin. Immunol., 113, 245-251 (2004).
8. Japanese Society of Allergology, "Japanese Guideline for the Diagnosis and Treatment of Allergic Diseases 2007," ed. by Nishima S., Kyowa Kikaku, Tokyo, 2007. (in Japanese)
9. Global Initiative forAsthma (GINA), "Global Strategy for Asthma Management and Prevention,": 〈http://www.ginasthma.org〉, cited 24 April, 2009.
10. US Department of Health and Human Services, "Expert Panel Report 3 (EPR3): Guidelines for the Diagnosis and Management of Asthma, Full Report 2007,":〈http://www.nhlbi.nih.gov / guidelines / asthma / asthgdln.htm〉, cited 24 April, 2009.
11. Petitti D. B., "Overview of the methods, Meta-Analysis, Decision Analysis and Costeffectiveness Analysis: Methods for Quantitative Synthesis in Medicine," ed. by Petitti D. B., Oxford University Press, New York, 2000, pp. 13-32.
12. Statistics & Information Department, Ministry's Secretariat, Ministry of Health, Labour and Welfare, "Survey of Medical Care Activities in Public Health Insurance 2006,":〈http: //wwwdbtk.mhlw.go.jp/toukei/ index.html〉, cited 24 April, 2009. (in Japanese)
13. Price M., Briggs A. H., Pharmacoeconomics, 23, 183-194 (2002).
14. Pharmaceuticals and Medical Devices Agency, "Approval Application forms of Adoair 100, 250, 500 Diskus (approved in April 2007), Chapter 2 of CTD summary,":〈http://www. info.pmda.go.jp / shinyaku / g070403 / index.html?〉, cited 24 April, 2009. (in Japanese)
15. Kavuru M., Gross G., LaForce C., House K., Prillaman B., Baitinger L., Woodring A., Shah T., Melamed J., J. Allergy Clin. Immunol., 105, 1108-1116 (2000).
16. Miyamoto T., Morita H., Tamura G., Tohda Y., Arakawa I., Shiragami M., Allergy, 55, 542-553 (2006). (in Japanese)
17. Central Social Insurance Medical Council, Committee Material for DPC Evaluation, "Average Duration of Hospitalization for Asthma Treatment in the 2005 Fiscal Year,": 〈http://www.mhlw.go.jp/shingi/2006/04/dl/ s0427-3d53.pdf〉, cited 24 April, 2009. (inJapanese)
18. Briggs A. H., "Handling Uncertainty in Economic Evaluation and Presenting the Results, Economic Evaluation in Health Care: Merging Theory with Practice," eds by Drummond M., McGuire A., Oxford University Press, New York, 2001, 172-214.
19. Miyagawa T., Arakawa I., Shiragami M., Nishimura S., Yakugaku Zasshi, 51-59 (2006).
20. Briggs A. H., Bousquet J., Wallace M. V., Allergy, 61, 531-536 (2006).
21. Doull I., Price D., Thomas M., Hawkins N., Stamuli E., Tabberer M., Gosden T., Rudge H., Curr. Med. Res. Opin., 23, 1147-1159 (2007).
22. Statistics & Information Department, Ministry's Secretariat, Ministry of Health, Labour and Welfare, "Patient Survey 2005,":〈http: //wwwdbtk.mhlw.go.jp/toukei/index.html〉, cited 24 April, 2009. (in Japanese)
23. Adachi M., Ohta K., Morikawa A., Nishima S., Tokunaga S., DiSanostefano R. L., Allergy, 57, 107-120 (2007). (in Japanese)
24. Drummond M., Pang F., "Transferability of Economic Evaluation Results, Economic Evaluation in Health Care: Merging Theory with Practice," eds. by Drummond M., McGuire A., Oxford University Press, New York, 2001, pp. 256-276.
25. Bjermer L., Bisgaard H., Bousquet J., Fabbri L. M., Greening A. P., Haahtela S. T., Holgate S. T., Picado C., Menten J., Dass S. B., Leff J. A., Polos P. G., BMJ, 327, 891-895 (2003).